scholarly journals “Beating osteoARThritis”: Development of a stepped care strategy to optimize utilization and timing of non-surgical treatment modalities for patients with hip or knee osteoarthritis

2011 ◽  
Vol 30 (12) ◽  
pp. 1623-1629 ◽  
Author(s):  
Agnes J. Smink ◽  
Cornelia H. M. van den Ende ◽  
Thea P. M. Vliet Vlieland ◽  
Bart A. Swierstra ◽  
Joke H. Kortland ◽  
...  
2017 ◽  
Vol 25 ◽  
pp. S347-S348
Author(s):  
L.K. King ◽  
E.J. Waugh ◽  
D.A. Marshall ◽  
G.A. Hawker

2021 ◽  
Vol 64 (3) ◽  
pp. 200-207
Author(s):  
Subum Lee ◽  
Dae-Chul Cho ◽  
Kyong-Tae Kim ◽  
Young-Seok Lee

The prevalence and medical costs of osteoporotic vertebral compression fractures (OVCFs) are on the rise. However, a concrete evidence-based treatment guideline has not yet been established. Despite that numerous randomized controlled trials (RCTs) were performed, the study design and outcome measurement were heterogeneous, and the results were not unified. The purpose of this review is to compare the results of high level-evidence studies to provide a background for evidence-based OVCF treatment. Many reports showed that vertebroplasty has better clinical outcomes than non-surgical treatment for OVCF, but the results of three double-blinded RCTs with the highest level of evidence did not show a significant difference between vertebroplasty and sham procedure. Whether undergoing surgical or non-surgical treatment, OVCF patient management should be started by managing osteoporosis first. Meanwhile, in the results of RCTs related to the comparison of conservative treatment modalities, the benefit of braces and a specific analgesic prescription protocol was also unclear. The presented results of each clinical trial were generally inconsistent and may not be appropriate in all situations. Any decision by clinicians to apply this evidence must be made considering individual patients and available resources. At present, controversy remains about the best treatment modality for OVCF. Large, multicenter, placebo/sham-controlled trials are needed to address this gap and establish strong evidence-based guidelines.


2021 ◽  
Vol 27 (7) ◽  
Author(s):  
Aatman Shah ◽  
Michael Tassavor ◽  
Sayesha Sharma ◽  
Bryan Tassavor ◽  
Richard Torbeck

2017 ◽  
Vol 102 (2) ◽  
pp. 158-163 ◽  
Author(s):  
Ana Beatriz Diniz Grisolia ◽  
Ricardo Christopher Couso ◽  
Suzana Matayoshi ◽  
Raymond S Douglas ◽  
César Augusto Briceño

Thyroid eye disease (TED) is an autoimmune condition with an unpredictable course that may lead to permanent facial disfigurement. Eyelid retraction is one of the most common findings, and frequently demands attention due to ocular exposure and impaired cosmesis. Surgical treatment remains the most effective option, but there is a role for temporary corrections during the active phase of the disease, as well as in patients who are poor surgical candidates. The aim of this review is to describe the non-surgical modalities currently available for treatment of eyelid malposition in TED. The authors have focused on the use of hyaluronic acid, triamcinolone injections and botulinum toxin type A as non-surgical treatment alternatives, paying special attention to dosing, technique, efficacy and duration of effect. Non-surgical treatment modalities may represent viable in cases where surgical correction is not an option. Although temporary, these modalities appear to be beneficial for ocular exposure remediation, improving quality of life and broadening our therapeutic arsenal.


Sign in / Sign up

Export Citation Format

Share Document